India Avenue on InvestNow
India Avenue offers the India Avenue Equity Fund – H Class (international equities) on the InvestNow platform.
Learn more about India Avenue, their investment options available to InvestNow customers plus access their latest news & updates.
India Avenue is one of 30+ specialist fund managers that have partnered with InvestNow.
How India Avenue describe themselves:
We are a specialist, boutique investment firm based in Sydney, Australia. Our firm is focused on providing simple but effective investment solutions for Australian and New Zealand based investors seeking to benefit from India’s strong economic growth by investing in its vibrant capital markets.
We have offices in Sydney, Australia and Mumbai, India and provide grassroots insights and knowledge to help clients understand the virtues and risks of investing in India for the purpose of achieving long-term growth in their investment portfolios.
Our Equity Fund holds at any time 40-60 listed Indian domiciled companies in its portfolio, which have exposure to India’s significantly, youthful and vibrant demographics. As the Indian economy experiences strong growth due to these demographics, it creates substantial opportunity for companies to grow their profits rapidly as consumer tastes and preferences evolve, the need for financial services increase and the requirements for infrastructure and manufacturing intensify.
India Avenue investment options
Below is the range of investment options from India Avenue that are available through the InvestNow platform. To see a full range of managed fund investment options available on InvestNow, please click here.
Using the table below:
To view more information about a fund and to view a Product Disclosure Statement, scroll to the right. To see a fund’s description on desktop, hover over the fund name. To see a fund’s description on mobile, click ‘read description’.
"Too Many Requests"
Important Information
- For a description of what each column heading means, please click here.
- The performance figures are for periods ending 30 November 2024.
- Past performance is not a guarantee of future returns. Returns are after fees, before tax and denominated in NZD. Performance figures over 1 year are annualised.
- Performance data is sourced from Morningstar or from the underlying fund manager.
- For any funds offered within the InvestNow KiwiSaver Scheme, the fund performance figures outlined are for the underlying funds that it invests into.
- Please note, the PDS fee is the manager’s estimated total annual fund charge as stated in the Product Disclosure Statement (PDS) for this fund. The Quarterly Fund Update (QFU) Fee is the latest actual total annual fund charge reported by the fund for its most recent financial year, as stated in the fund’s most recent Quarterly Fund Update. Both figures include any applicable GST as well as any performance-based fees if applicable.
- Transaction-based charges may also apply when you buy or sell a fund, which could include buy/sell spreads (as outlined in the buy/sell spread column), entry/exit fees (denoted by * in the buy/sell spread column), or swing pricing adjustments (denoted by ** in the buy/sell spread column). Please see the PDS for full details on the charges that can apply.
- Managed funds in New Zealand must have a standard risk indicator. The risk indicator is designed to help investors understand the uncertainties both for loss and growth that may affect their investment. You can compare funds using the risk indicator – 1 is lower risk and potentially lower returns, while 7 is higher risk and potentially higher returns.
Latest news & updates from India Avenue
Monthly Report – September 2024
Monthly Report – September 2024
In the latest monthly update, the team at India Avenue discuss the positioning and performance of the Fund and provide an overview of a portfolio holding operating in the non-banking finance sector.
Marksans Pharma – A tiger in India’s emerging pharmaceutical industry
Marksans Pharma – A tiger in India’s emerging pharmaceutical industry
October 2024
Marksans Pharma is riding the wave of India’s pharmaceutical dominance and is emerging as a global powerhouse. As India cements its position as the “pharmacy of the world,” Marksans is leading the charge with cutting-edge R&D, cost-efficient manufacturing, and a strong international presence.
Monthly Report – August 2024
Monthly Report – August 2024
In the latest monthly update, the team at India Avenue discuss the positioning and performance of the Fund and provides an overview of a portfolio holding operating in the pharmaceutical sector.
Amara Raja Energy & Mobility: Steering India Towards a Sustainable Future
Amara Raja Energy & Mobility: Steering India Towards a Sustainable Future
September 2024
Amara Raja Energy & Mobility Ltd, is a company listed on India’s stock exchanges, with a market capitalisation of NZ$5.6 billion. It has grown through innovation and by participation in the rapidly transforming Indian energy landscape.
Monthly Report – July 2024
Monthly Report – July 2024
In the latest monthly update, the team at India Avenue discuss the positioning and performance of the Fund and provides an overview of a portfolio holding operating in the battery industry.
Phoenix Mills: An attractive Real Estate & Consumption Story
Phoenix Mills: An attractive Real Estate & Consumption Story
August 2024
India’s real estate and hospitality sectors have seen remarkable transformations over the past few decades, evolving from traditional and fragmented markets into organised and rapidly growing industries. The real estate sector has been a cornerstone of India’s economic development, contributing significantly to GDP and employment.
Riding High Again: Hero MotoCorp
Riding High Again: Hero MotoCorp
July 2024
India’s two-wheeler market has been a vital component of the country’s transportation sector, with roughly 75% of the population depending on two-wheelers for their daily commute and shuttle. This dominance can be traced to the early 1980s when the Indian auto market saw a surge in demand for affordable and efficient modes of transportation.
Monthly Report – May 2024
Monthly Report – May 2024
In the latest monthly update, the team at India Avenue provide some thoughts on the implications of the recent general election, discuss the positioning and performance of the Fund and provides an overview of a portfolio holding operating in the motor industry.
Empowering India’s Underserved: Cholamandalam Investment & Finance
Empowering India’s Underserved: Cholamandalam Investment & Finance
June 2024
India’s financial landscape is rapidly evolving, driven by rising financialisation, formalisation, and digitisation. With over 1.4 billion people, including a sizable rural population (urbanisation rate approximately 36%), India presents vast opportunities for financial sector companies to expand access to finance.
India’s General Election Update – “Democracy wins in India”
India’s General Election Update – “Democracy wins in India”
June 2024
India recently held its national elections with close to 650 million people going to the polls and over seven phases. The result saw Narendra Modi win a third consecutive term as Prime Minister, but in a much tighter election race than anticipated. India Avenue has produced an update on the election results and what it might mean for Government policy, the economy and markets going forward.
Monthly Report – April 2024
Monthly Report – April 2024
The Fund returned 3.43% (H Class Units) over the last three months to 30 April 2024, underperforming its benchmark by 4.45%.
Charting the Skies: Harnessing India’s Demographic Dividend
Charting the Skies: Harnessing India’s Demographic Dividend
17 May 2024
Supported by demographic tailwinds, rising wealth, and changing consumer patterns, travel in India is developing rapidly. In this article, we examine growth in air travel, and how one airline company, Interglobe Aviation, is benefitting.
Monthly Report – March 2024
Monthly Report – March 2024
The Fund returned 3.70% (H Class Units) over the first quarter of 2024, underperforming its benchmark over the same period by 7.24%.
Grass Roots Tour IV Summary
Grass Roots Tour IV Summary
16 April 2024
Our Grassroots India Tour IV took place from February 18-23rd in the cities of Mumbai, Chennai and Bengaluru.
Monthly Report – Jan 2024
Monthly Report – Jan 2024
The Fund returned 13.16% (H Class Units) over the last quarter, outperforming its benchmark over the same period by 0.04%.
Monthly Report – Dec 2023
Monthly Report – Dec 2023
The Fund returned 5.20% (H class units) over the last quarter of 2023, underperforming its benchmark over the period by 0.64%. Over the calendar year of 2023, the Fund returned 28.25%, outperforming its benchmark by 8.19%.
Monthly Report – Nov 2023
Monthly Report – Nov 2023
The Fund has delivered a return of 20.46% per annum over the last three years, and thereby outperforming its benchmark by 3.74% per annum. Our performance drivers include a bias towards mid and small caps, with overweight positions in the Healthcare sector (predominantly Pharmaceuticals) and Real Estate sectors.
10 Things I Love About India
10 Things I Love About India
India’s economic growth and equity market returns have been second to none amongst major economies / equity market indices, yet investors have been slow off the starting grid, when it comes to direct allocation to the region.
Mugunthan Siva,
MD, India Avenue IM
Monthly Report – Oct 2023
Monthly Report – Oct 2023
The Fund (H Class) returned -1.76% in the month of October 2023, underperforming its benchmark by 0.66% over the month. However, over the last 12 months the Fund has outperformed its benchmark by 5.82% due to its positioning with a bias to mid and small caps, relative to the benchmark. The Fund has also benefitted from appropriate sector allocation and stock selection over this period.
Monthly Report – Sept 2023
Monthly Report – Sept 2023
The Fund (H Class) underperformed its benchmark by 0.62% over the month. However, over the September quarter the Fund outperformed its benchmark by 3.54%. The Fund’s mid and small cap bias has led to outperformance of 3.86% over the last 12 months.
Indian equities align to long-term expectations…so far this century
Indian equities align to long-term expectations…so far this century
Given India’s pace of economic growth, reforms and infrastructure development and its youthful, entrepreneurial and large population, investors typically look to achieve and to benefit from capital growth by investing in the region. Unfortunately, investment returns don’t always work out as
hoped, usually due to “unplanned” adversity. This might include events like the Global Financial Crisis, the COVID-19 pandemic or India specific issues like rising oil prices, political instability, stagflation and a volatile currency.
Monthly Report – Aug 2023
Monthly Report – Aug 2023
The Fund (H Class) returned 3.94% in the month of August 2023, outperforming its benchmark by 1.87% over the period. Over the last quarter the Fund outperformed by 4.62%, driven by the relative outperformance of mid and small cap stocks over large cap stocks, the latter of which has a greater weighting in the market capitalisation weighted, MSCI India.
Monthly Report – July 2023
Monthly Report – July 2023
The Fund returned 3.90% in the month of July 2023, outperforming its benchmark by 2.17%. This was driven by outperformance of small and mid-cap stocks relative to large caps. In the year to date, the Nifty 50 (largest 50 stocks by market cap) has returned 9.8% in comparison to mid-caps, 19.4% and small caps, 20.2%.
Reasons to consider investing in India in the 2020’s
Reasons to consider investing in India in the 2020’s
It’s been 3 years since the commencement of the 2020’s and after a rough start for equity markets with the onset of the Covid-19 pandemic, some markets have rebounded strongly. It was expected that India would be one of the most impacted in terms of livelihood, hardship and economically.
India Avenue Equity Fund Factsheet June 2023
The Fund returned 2.23% in the month of June 2023, outperforming its benchmark by 0.44%. This was driven by continued outperformance by small and mid-cap stocks relative to large caps. Over the last 12 months, returns from the Indian market have been strong relative …